These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10974389)

  • 1. The effect of a water/organic solvent interface on the structural stability of lysozyme.
    van de Weert M; Hoechstetter J; Hennink WE; Crommelin DJ
    J Control Release; 2000 Sep; 68(3):351-9. PubMed ID: 10974389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C; Griebenow K
    Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
    Cleland JL; Jones AJ
    Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method.
    Pérez C; De Jesús P; Griebenow K
    Int J Pharm; 2002 Nov; 248(1-2):193-206. PubMed ID: 12429473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
    Taluja A; Bae YH
    Int J Pharm; 2008 Jun; 358(1-2):50-9. PubMed ID: 18395374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of lysozyme by sonication under conditions relevant to microencapsulation.
    Krishnamurthy R; Lumpkin JA; Sridhar R
    Int J Pharm; 2000 Sep; 205(1-2):23-34. PubMed ID: 11000539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres.
    Fu K; Griebenow K; Hsieh L; Klibanov AM; LangerR
    J Control Release; 1999 Apr; 58(3):357-66. PubMed ID: 10099160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres.
    Pérez-Rodriguez C; Montano N; Gonzalez K; Griebenow K
    J Control Release; 2003 Apr; 89(1):71-85. PubMed ID: 12695064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation.
    Sah H
    J Control Release; 1999 Mar; 58(2):143-51. PubMed ID: 10053187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates.
    Nam YS; Park TG
    J Microencapsul; 1999; 16(5):625-37. PubMed ID: 10499842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved activity and stability of lysozyme at the water/CH2Cl2 interface: enzyme unfolding and aggregation and its prevention by polyols.
    Pérez C; Griebenow K
    J Pharm Pharmacol; 2001 Sep; 53(9):1217-26. PubMed ID: 11578104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.
    Taluja A; Bae YH
    Mol Pharm; 2007; 4(4):561-70. PubMed ID: 17439239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process.
    Cho M; Sah H
    J Microencapsul; 2005 Feb; 22(1):1-12. PubMed ID: 16019886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein.
    Carrasquillo KG; Stanley AM; Aponte-Carro JC; De Jésus P; Costantino HR; Bosques CJ; Griebenow K
    J Control Release; 2001 Oct; 76(3):199-208. PubMed ID: 11578736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres.
    Sah H
    PDA J Pharm Sci Technol; 1999; 53(1):3-10. PubMed ID: 10343502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational stability of a model protein (bovine serum albumin) during primary emulsification process of PLGA microspheres synthesis.
    Kang F; Singh J
    Int J Pharm; 2003 Jul; 260(1):149-56. PubMed ID: 12818819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques.
    van de Weert M; van 't Hof1 R; van der Weerd J; Heeren RM; Posthuma G; Hennink WE; Crommelin DJ
    J Control Release; 2000 Jul; 68(1):31-40. PubMed ID: 10884577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles.
    Srinivasan C; Katare YK; Muthukumaran T; Panda AK
    J Microencapsul; 2005 Mar; 22(2):127-38. PubMed ID: 16019899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.